Skip to content

The effect of subcision on acne scar

Evaluation of Efficacy of BBSB type C in comparison with needle subcision on atrophic acne scar

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20111121008146N29
Enrollment
32
Registered
2018-01-21
Start date
2017-02-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic acne scar. Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention 1: Intervention group1:The A side is required to be subcision to BBSB type C. The site of the entry of the subcision blade is at a point in the 1 cm front and 2 cm ahead of the ear tragus
Treatment - Devices
Intervention group1:The A side is required to be subcision to BBSB type C. The site of the entry of the subcision blade is at a point in the 1 cm front and 2 cm ahead of the ear tragus. Iodine is used
Intervention group2: On the B side, perform the subcision with the needle number 22. After determining the range and location of atrophic scars with non-toxic surgical markers, the range is averaged b

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age 18 to 50 years old Patient's complete consent to participate in the study Acne atrophic scars on both sides of the species with a relatively uniform intensity on both sides

Exclusion criteria

Exclusion criteria: Active nodulosistic acne (more than 6 papules or nodules on each side of the face) Active skin infection ( herpes simplex or jaundice infection) Hematological disorders or coagulopathy Immunosuppression Dermatological diseases interfere with the procedure Previous biography of colloids Taking medications that prolong the bleeding time (especially aspirin, warfarin or vitamin E) Isotretinoin intake over the past 12 months Performing resurfacing procedures over the past 6 months include dermabrasion, laser therapy, chemical peeling Pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frame
Severity of atrophic scars. Timepoint: Before starting treatment, in the first week after treatment, the first month, the third month and the sixth month after treatment. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Behrouz Barikbin

Shahid Beheshti University of Medical Sciences

laser.cntr@yahoo.com+98 21 2274 9221

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026